Substance: Trenbolone Acetate
Package: 10 ampoules (100mg / ml)

SKU: 513 Category: Tag:

Buy Trenoprime (Trenbolone Acetate) in Italy

Trenbolone Acetate is a widely used injectable anabolic androgenic steroid, which provides a perfect result in both bulking and contest prep cycles. This multifunctionality of use is caused by its active ingredient, Trenbolone Acetate Italy. The growth of incredibly hard muscles is the result of the use of Trenbolone Acetate.

Trenbolone Acetate, has the ability to burn fat in the body, which is why it is used in cutting cycles before competitions. During bulking cycles, the bodybuilder will appreciate its ability to retain nitrogen in the muscles and promote the production of protein, which allows for faster muscle growth. Trenbolone Acetate can help with muscle regeneration. The product does not cause excessive water retention, for this reason the body weight is not high, simultaneously with the growth of the muscles.

For best results, bodybuilders often stack Trenbolone Acetate with methenolone, oxandrolone –, nandrolone decanoate or drostanolone.

Trenoprime (Trenbolone Acetate) Dosage

Men usually use a maximum of 60 mg of Trenbolone Acetate a day. Beginner steroids shouldnt go beyond the 25mg per day border. You can use Trenbolone Acetate for up to 10 weeks. If some of the side effects occur, you can use the product immediately. Women should not use the product, as it leads to virilization.

Trenoprime Side Effects (Trenbolone Acetate)

Among the standard side effect is acne, increased aggression, hair loss or headache. Hypertension or prostatic hypertrophy may appear, as well. However, Trenbolone Acetate Italy can cause serious health problems, as well. It is toxic to the liver and kidneys and could be a direct cause of cancer of these organs in extreme cases. The product has negative effects of the natural endogenous production of testosterone and can lead to sexual dysfunction

There are no reviews yet.

Be the first to review “Trenoprime”

Your email address will not be published. Required fields are marked *